169 related articles for article (PubMed ID: 30817887)
1. Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa.
Chen Q; Shah KN; Zhang F; Salazar AJ; Shah PN; Li R; Sacchettini JC; Wooley KL; Cannon CL
Mol Pharm; 2019 Apr; 16(4):1606-1619. PubMed ID: 30817887
[TBL] [Abstract][Full Text] [Related]
2. A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver Nanoparticles.
Jasim R; Schneider EK; Han M; Azad MAK; Hussein M; Nowell C; Baker MA; Wang J; Li J; Velkov T
J Biomed Nanotechnol; 2017 Apr; 13(4):447-57. PubMed ID: 29384621
[TBL] [Abstract][Full Text] [Related]
3. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
Yuan YG; Peng QL; Gurunathan S
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
[TBL] [Abstract][Full Text] [Related]
4. Effect of Graphene Oxide and Silver Nanoparticles Hybrid Composite on
Lozovskis P; Jankauskaitė V; Guobienė A; Kareivienė V; Vitkauskienė A
Int J Nanomedicine; 2020; 15():5147-5163. PubMed ID: 32764942
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant
Liao S; Zhang Y; Pan X; Zhu F; Jiang C; Liu Q; Cheng Z; Dai G; Wu G; Wang L; Chen L
Int J Nanomedicine; 2019; 14():1469-1487. PubMed ID: 30880959
[TBL] [Abstract][Full Text] [Related]
6. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms.
Habash MB; Park AJ; Vis EC; Harris RJ; Khursigara CM
Antimicrob Agents Chemother; 2014 Oct; 58(10):5818-30. PubMed ID: 25049240
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
8. A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model.
Shah PN; Shah KN; Smolen JA; Tagaev JA; Torrealba J; Zhou L; Zhang S; Zhang F; Wagers PO; Panzner MJ; Youngs WJ; Wooley KL; Cannon CL
Sci Rep; 2018 Apr; 8(1):6376. PubMed ID: 29686296
[TBL] [Abstract][Full Text] [Related]
9. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles.
Markowska K; Grudniak AM; Krawczyk K; Wróbel I; Wolska KI
J Med Microbiol; 2014 Jun; 63(Pt 6):849-854. PubMed ID: 24623636
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
Al-Obaidi H; Kalgudi R; Zariwala MG
Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
Nour El Din S; El-Tayeb TA; Abou-Aisha K; El-Azizi M
Int J Nanomedicine; 2016; 11():1749-58. PubMed ID: 27175075
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
Saiman L
Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa.
Mapara N; Sharma M; Shriram V; Bharadwaj R; Mohite KC; Kumar V
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10655-67. PubMed ID: 26362684
[TBL] [Abstract][Full Text] [Related]
14. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
Sans-Serramitjana E; Fusté E; Martínez-Garriga B; Merlos A; Pastor M; Pedraz JL; Esquisabel A; Bachiller D; Vinuesa T; Viñas M
J Cyst Fibros; 2016 Sep; 15(5):611-8. PubMed ID: 26708265
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by
Salman M; Rizwana R; Khan H; Munir I; Hamayun M; Iqbal A; Rehman A; Amin K; Ahmed G; Khan M; Khan A; Amin FU
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2465-2472. PubMed ID: 31187657
[No Abstract] [Full Text] [Related]
16. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections.
Kasithevar M; Periakaruppan P; Muthupandian S; Mohan M
Microb Pathog; 2017 Jun; 107():327-334. PubMed ID: 28411059
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R
Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Balke B; Hogardt M; Schmoldt S; Hoy L; Weissbrodt H; Häussler S
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):25-30. PubMed ID: 16402226
[TBL] [Abstract][Full Text] [Related]
20. In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Ma W; Li J; Wang D; Yu C; Sun S
Lett Appl Microbiol; 2019 Sep; 69(3):198-203. PubMed ID: 31236975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
